Clinical Trial Update: Emboshield® and Xact® Post Approval Carotid Stent Trial (The EXACT Study) [Phase 4]

View source ↗

Summary

This Phase 4 post-approval trial evaluating Emboshield embolic protection device and the Xact carotid stent has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Carotid Artery Disease
• Carotid Stenosis
• Stroke

Drugs mentioned

• Emboshield
• Xact Carotid Stent

Snippet

Sponsor: Abbott Medical Devices | Conditions: Carotid Artery Disease, Carotid Stenosis | Phase 4 | Status: COMPLETED